股票代码：600160 股票简称：巨化股份 公告编号：临 2023-45 被担保人名称 浙江巨化股份有限公司（以下简称"公司"或"本公司"）之全资子公司巨化贸 易（香港）有限公司（以下简称"香港贸易公司"）；控股子公司浙江晋巨化工有限 公司（以下简称"晋巨公司"）。 担保金额及已实际为其提供的担保余额 本次新增为晋巨公司、香港贸易公司六笔融资提供担保，合计担保金额人民 币 8617.33 万元。其中新增为晋巨公司一笔融资提供担保 1064.50 万元；新增为 香港贸易公司五笔融资提供担保，合计担保金额 1063.51 万美元，折合成人民币 7552.83 万元（汇率按中国人民银行官网 11 月 30 日中间价 7.1018）。 截止本公告日，本公司为上述被担保人提供的担保余额为 84030.17 万元。 其中：为晋巨公司提供担保的余额为 70284.24 万元(含项目建设资金担保余额 54484.48 万元)；为香港贸易公司提供的担保余额为 1935.56 万美元，折合成人 民币 13745.93 万元。 本次担保无反担保 特别风险提示：本次被担保对象晋巨公司资产负债率超过70%，为公司 控股子公司，财务风险 ...

浙江巨化股份有限公司独立董事工作制度 （经 2023 年 12 月 5 日董事会九届六次会议审议通过） 第一章 总则 第一条 为进一步完善浙江巨化股份有限公司（以下简称"公司"）的治理 结构，促进公司的规范运作，充分发挥独立董事在公司治理中的作用，根据《中 华人民共和国公司法》《上市公司独立董事管理办法》《上海证券交易所股票上 市规则》《上海证券交易所上市公司自律监管指引第 1 号——规范运作》和《浙 江巨化股份有限公司章程》(以下简称"《公司章程》")等相关规定，制定本制 度。 第二条 独立董事是指不在公司担任除董事外的其他职务，并与公司及主要 股东、实际控制人不存在直接或者间接利害关系，或者其他可能影响其进行独立 客观判断关系的董事。 独立董事应当独立履行职责，不受公司及其主要股东、实际控制人等单位或 者个人的影响。 第三条 独立董事对公司及全体股东负有诚信与勤勉义务，并应当按照相关 法律法规和《公司章程》的要求，认真履行职责，在董事会中发挥参与决策、监 督制衡、专业咨询作用，维护公司整体利益，保护中小股东合法权益。 第四条 公司董事会成员中应当至少包括三分之一独立董事，且至少包括一 名会计专业人士。 公 ...

股票代码：600160 股票简称：巨化股份 公告编号：临 2023-43 浙江巨化股份有限公司 董事会九届六次（通讯方式）会议决议公告 1 具体内容详见公司临2023-44号《浙江巨化股份有限公司收购股权公告》。 特此公告。 浙江巨化股份有限公司（以下简称"公司"）董事会于 2023 年 11 月 24 日以 电子邮件、书面送达等方式向公司董事发出召开董事会九届六次会议（以下简称 "会议"）的通知。会议于 2023 年 12 月 5 日以通讯方式召开。会议应出席董事 12 人，实际出席 12 人。会议的召集、召开符合有关法律、行政法规、部门规章、 规范性文件和公司章程的规定。与会董事经认真审议后，做出如下决议： 浙江巨化股份有限公司董事会 2023 年 12 月 6 日 一、以 12 票同意、0 票反对、0 票弃权，通过关于修订《浙江巨化股份有限 公司独立董事工作制度》的议案。 修订后的《浙江巨化股份有限公司独立董事工作制度》详见上海证券交易所 网站 www.sse.com.cn。 二、以 12 票同意、0 票反对、0 票弃权，通过《浙江巨化股份有限公司关于 收购淄博飞源化工有限公司部分股权并对其增资的议案》 ...

股票代码：600160 股票简称：巨化股份 公告编号：临 2023－44 浙江巨化股份有限公司收购股权公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 浙江巨化股份有限公司（以下简称 "公司"或"本公司"）拟以现金出资方 式，收购淄博飞源化工有限公司（以下简称"飞源化工"或"标的公司"）部分老股 东持有标的公司 5,469.6033 万股权（占标的公司全部股权的 30.146%），同时单方面 增加标的公司注册资本 7,721.8322 万，合计取得标的公司 51%股权（以下合称"本次 交易"）。本次交易金额 139,448.6 万元。其中：收购标的公司股权金额 57,819.98 万元；单方面对标的公司增资金额 81,628.62 万元（具体以公司签订的交易协议为准， 下同）。 本次交易各方协商确定飞源化工 100%股权价值为 191,800 万元（折合 10.5711 元 /注册资本），与标的公司合并财务报表中归属于母公司的净资产相比增值 124,527.96 万元，增值率为 185.11%；与标的公司母 ...

股票简称：巨化股份 股票代码：600160 公告编号：临 2023-42 浙江巨化股份有限公司关于担保进展情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 被担保人名称 浙江巨化股份有限公司（以下简称"公司"或"本公司"）控股子公司浙江晋巨 化工有限公司（以下简称"晋巨公司"）。 担保金额及已实际为其提供的担保余额 本次新增为晋巨公司三笔融资提供担保，合计担保金额 4,207.09 万元。其 中经公司 2022 年年度股东大会审议通过，在 2023 年年度预计范围内为晋巨公司 提供两笔担保，合计担保金额 2559.49 万元；经公司董事会八届十八次审议通过， 为晋巨公司提供担保 1647.6 万元。截止本公告日，本公司为晋巨公司提供担保 的余额为 70,743.77 万元(其中项目建设资金担保余额 54,690.43 万元)。 特别风险提示：本次被担保对象晋巨公司资产负债率超过70%，为公司 控股子公司，财务风险处于可控范围内，敬请投资者注意相关风险。 一、担保情况概述 经公司董事会八届九次批准 ...

Financial Performance - The company's operating revenue for Q3 2023 was CNY 5,916,717,347.45, representing a year-on-year increase of 0.75%[4] - The net profit attributable to shareholders for Q3 2023 was CNY 256,946,231.04, a decrease of 65.54% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2023 was CNY 232,675,077.91, down 68.48% year-on-year[4] - The basic earnings per share for Q3 2023 was CNY 0.095, a decline of 65.58% compared to the same period last year[8] - The operating profit for Q3 2023 was CNY 847.91 million, down 56.7% from CNY 1.96 billion in Q3 2022[17] - The total comprehensive income for Q3 2023 was CNY 755.90 million, compared to CNY 1.72 billion in Q3 2022[17] Revenue and Costs - Total operating revenue for the first three quarters of 2023 was CNY 16,012,658,034.42, a decrease of 2.22% compared to CNY 16,376,949,892.35 in the same period of 2022[16] - Total operating costs increased to CNY 15,412,484,114.81, up 5.15% from CNY 14,657,900,309.31 year-on-year[16] - Research and development expenses rose significantly to CNY 738,562,635.63, an increase of 31.08% compared to CNY 563,160,270.45 in the previous year[16] Assets and Liabilities - The total assets at the end of the reporting period were CNY 23,097,914,715.75, an increase of 2.08% compared to the end of the previous year[5] - The company's total assets as of September 30, 2023, were CNY 23,097,914,715.75, compared to CNY 22,626,691,196.94 at the end of 2022[15] - Current liabilities totaled CNY 5,112,649,313.79, an increase from CNY 4,903,981,835.40 in the previous year[14] - The total liabilities increased to CNY 7,264,069,653.81 from CNY 6,842,255,673.14, suggesting a rise in financial leverage[14] Cash Flow - The net cash flow from operating activities for the year-to-date period was CNY 703,018,100.02, down 70.93% year-on-year[4] - The cash flow from operating activities for the first nine months of 2023 was CNY 703.02 million, a significant decrease from CNY 2.42 billion in the same period of 2022[19] - The company reported a net cash outflow from investing activities of CNY 845.34 million in Q3 2023, compared to a net outflow of CNY 1.75 billion in Q3 2022[19] - The cash and cash equivalents decreased to CNY 1,769,729,308.58 from CNY 2,547,268,714.78, reflecting a liquidity contraction[12] - The cash and cash equivalents at the end of Q3 2023 were CNY 1.31 billion, down from CNY 2.37 billion at the end of Q3 2022[19] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 51,470[10] - The largest shareholder, Juhua Group Co., Ltd., held 52.70% of the shares[10] Investments and Receivables - Long-term equity investments increased to CNY 2,025,477,618.28 from CNY 1,851,740,741.10 year-on-year, indicating a growth in investment strategy[13] - The company reported a significant increase in accounts receivable, which rose to CNY 1,474,899,953.48 from CNY 980,426,719.78, indicating potential credit risk[13] Other Financial Metrics - The weighted average return on equity for Q3 2023 was 1.67%, a decrease of 3.53 percentage points from the previous year[5] - The total assets impairment loss for Q3 2023 was CNY 1.56 million, a significant decrease from CNY 83.77 million in Q3 2022[17] - The company recorded a foreign exchange gain of CNY 18.09 million in Q3 2023, compared to a gain of CNY 61.54 million in Q3 2022[19]

会议召开方式：上证路演中心网络互动 问题征集方式：投资者可于 2023 年 10 月 27 日(星期五) 至 11 月 02 日(星期四)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通 过公司信箱 zhuli@juhua.com 向公司提问，公司将在本次说明会上就投资者普 遍关注的问题进行回答。 浙江巨化股份有限公司（以下简称"公司"）已于 2023 年 10 月 27 日披露 《公司 2023 年第三季度报告》，为便于广大投资者更全面深入地了解公司 2023 年三季度经营成果、财务状况等情况。公司计划于 2023 年 11 月 03 日下午 15:00- 16:00 举行 2023 年第三季度业绩说明会，就投资者关心的问题进行交流。 一、说明会类型 股票代码：600160 股票简称：巨化股份 公告编号：临 2023-40 浙江巨化股份有限公司 关于召开 2023 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： http://roadshow.sseinfo. ...

股票代码：600160 股票简称：巨化股份 公告编号：临 2023－41 浙江巨化股份有限公司 2023 年 1-9 月主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 浙江巨化股份有限公司（以下简称"公司"）根据《上海证券交易所上市公司 自律监管指引第 3 号——行业信息披露（第十三号化工）》有关规定，将公司 2023 年 1-9 月（以下简称"报告期"）主要经营数据披露如下： | 主要产品 | 产量 | 同比 | 外销量 | 同比 | 营业收入 | 同比 | | --- | --- | --- | --- | --- | --- | --- | | | 吨 | % | 吨 | % | 万元 | % | | 氟化工原料 | 794712.17 | 19.06 | 264207.13 | 29.36 | 78088.31 | -24.71 | | 致冷剂 | 362452.93 | -11.25 | 221170.29 | -7.74 | 436930.44 | -14.68 | | 其中：HFCs | ...

股票代码：600160 股票简称：巨化股份 公告编号：临 2023-38 浙江巨化股份有限公司 关于公司担保进展情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 被担保人名称 浙江巨化股份有限公司（以下简称"公司"或"本公司"）控股子公司浙江晋巨 化工有限公司（以下简称"晋巨公司"）。 担保金额及已实际为其提供的担保余额 本次新增为晋巨公司一笔融资提供担保，担保金额 1,647.6 万元。截止本公 告日，本公司为晋巨公司提供担保的余额为 70,948.95 万元(其中项目建设资金 担保余额 56,013.46 万元)。 本次担保无反担保 除对子公司担保外，公司无其他对外担保 公司无逾期对外担保 特别风险提示：本次被担保对象晋巨公司资产负债率超过70%，为公司 控股子公司，财务风险处于可控范围内，敬请投资者注意相关风险。 一、担保情况概述 经公司董事会八届九次批准计划为控股子公司晋巨公司项目建设资金提供 贷款连带责任担保不超过人民币 82,380 万元（担保期限 8-12 年）；经公司 2022 ...

Financial Performance - The company reported a significant increase in revenue, achieving a total of $X million for the first half of 2023, representing a Y% growth compared to the same period last year[10]. - The company reported a significant increase in revenue, driven by strong demand for its chemical products, with a year-over-year growth of 15%[11]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion CNY for the first half of 2023, representing a 15% year-over-year growth[18]. - The company provided an optimistic outlook for the next quarter, projecting revenue growth of B% and an increase in user engagement metrics[10]. - The company projects a revenue growth of 10% for the next fiscal year, supported by new product launches and market expansion strategies[11]. - The company has provided a positive outlook for the second half of 2023, projecting a revenue growth of 10% to 12%[18]. - The company reported a net profit attributable to shareholders was ¥489,836,288.26, reflecting a significant decline of 48.61% year-over-year[23]. - The company reported a net profit of approximately ¥3,191,649,848.42, contributing to the overall increase in equity[160]. Research and Development - The company is actively involved in research and development of new materials and technologies[9]. - Research and development efforts are being intensified, with a budget allocation of $H million aimed at developing next-generation products[10]. - Investment in R&D for new technologies is expected to increase by 25%, focusing on environmentally friendly chemical solutions[11]. - The company completed R&D investments of 498 million yuan, focusing on advanced fluorochemical materials and new green refrigerants[80]. - The company is committed to innovation and aims to complete its annual R&D and fixed asset investment plans to foster new economic growth points[85]. Market Expansion and Strategy - The company is expanding its market presence in regions D and E, targeting a market share increase of F% by the end of 2024[10]. - The company plans to expand its market presence in Asia, targeting a 30% increase in sales in the region over the next two years[11]. - The company is actively pursuing market expansion opportunities in the field of chemical materials, particularly in high-performance applications[14]. - The company is exploring market expansion opportunities in the refrigeration and air conditioning sectors, leveraging its innovative refrigerant solutions[12]. - The company is expanding its market presence in Southeast Asia, targeting a 25% market share by the end of 2024[18]. Environmental Commitment - The report emphasizes the importance of the Montreal Protocol and its Kigali Amendment for environmental compliance[9]. - The company is committed to sustainability initiatives, with plans to reduce carbon emissions by K% over the next five years[10]. - The company is committed to sustainability, with plans to reduce carbon emissions by 30% over the next five years[11]. - The company is committed to enhancing its environmental measures and adopting new technologies to reduce emissions and pollution[99]. - The company aims for "zero pollution, zero accidents, and zero harm" in its environmental management goals[112]. Financial Management - The company has not provided any guarantees to shareholders, actual controllers, or their related parties[130]. - The total guarantee amount provided to entities with a debt ratio exceeding 70% is CNY 70,998.38 million[130]. - The company has a registered capital of 2,699,746,081.00 CNY, with a total of 2,699,746,081 shares outstanding[166]. - The company’s total liabilities to equity ratio increased to approximately 0.49 from 0.43, indicating a higher leverage position[137]. - The company’s total liabilities were approximately ¥1,287,406,152.58, suggesting a stable financial position relative to its assets[156]. Operational Efficiency - The company is implementing new strategies to improve operational efficiency, aiming for a cost reduction of I% by the end of the fiscal year[10]. - The company aims to reduce production costs by 10% through improved operational efficiencies and supply chain optimization[11]. - The company aims to enhance safety and operational efficiency, focusing on zero hazards and zero risks, while implementing lean management practices[84]. - The company is committed to improving its operational efficiency in the production of caustic soda, which is essential for various industrial applications[15]. Risk Management - The report includes a detailed description of potential risks faced by the company, which investors are advised to review[4]. - The company is facing safety production risks due to the hazardous nature of the chemical industry, emphasizing the need for strict management and safety protocols[97]. - Environmental risks are heightened due to stricter regulations, with potential impacts on operational performance and increased costs for compliance[98]. - Market risks are present due to cyclical fluctuations in the chemical industry, which are closely tied to macroeconomic conditions and demand levels[100]. Corporate Governance - The board of directors confirmed the authenticity, accuracy, and completeness of the semi-annual report, with all directors present at the meeting[2]. - The company held its first extraordinary general meeting on April 7, 2023, electing new members to the ninth board of directors and supervisory board[107]. - The annual general meeting on June 2, 2023, approved the 2022 financial report and the 2023 financial budget[107]. - The company has been recognized for its internal control and information disclosure, being selected for the "Top 30 Internal Control of Zhejiang Listed Companies" for six consecutive years[60]. Product Development - The company is focusing on the production of new fluorinated solvents, which have applications in pharmaceuticals, pesticides, and fine chemical intermediates[14]. - The company reported a significant focus on the development and application of various refrigerants, including R134a, R143a, and R125, which are widely used in refrigeration and air conditioning systems[12]. - The introduction of new refrigerants is expected to capture a larger market segment, with projected sales growth of 15% in this category[11]. - The company is expanding its product line to include perfluoropolyether thermal conductive fluids, which are widely used in semiconductor production and data center cooling systems[14].